Legend scientific founder returns to ASCO with new ambition for high-yield, non-gene-editing CAR-T platform Read more
AstraZeneca, after phase 3 miss, posts subgroup data behind pitch for rare disease approval Read more
Agios’ next-gen PK drug fails blood cancer study but sickle cell disease ambitions remain undimmed Read more
March 5, 2025 @ 8:30 am

We are pleased to announce the next OBN C-Suite Breakfast Discussion, hosted by New England Biolabs Lyophilization Sciences at their new Milton Park site, Oxfordshire, on 5 March. This exclusive event will focus on how UK-based R&D SMEs in the life sciences sector can “Penetrate the US Market.” Keynote speakers include Laurie Spicer, Director of US Expansion at Foothold America, and Barney Balmforth, Co-Founder & CEO of Biofidelity. The discussion will explore key topics such as understanding the US healthcare sector, validating technologies, and developing effective partnering strategies to support successful growth.
The event will also feature a moderated round-table discussion for senior leaders in life sciences. This event is designed to foster high-level discussions, offering valuable thought leadership and practical insights for driving growth.